[journal]
Folkman J
/ 1971
/ Tumor angiogenesis : therapeutic implications
/ New Eng J Med
285
: 1182~1186
[journal]
Cook KM.
/ 2010
/ Angiogenesis inhibitors : current strategies and future prospects
/ CA Cancer J Clin
60
: 222~243
[journal]
Bergers G.
/ 2003
/ Tumorigenesis and the angiogenic switch
/ Nat Rev Cancer
3
: 401~410
[journal]
Folkman J
/ 1990
/ What is the evidence that tumors are angiogenesis dependent?
/ J Natl Cancer Inst
82
: 4~6
[journal]
Verheul HM.
/ 2004
/ Are tumors angiogenesis-dependent?
/ J Pathol
202
: 5~13
[journal]
Folkman J
/ 2007
/ Angiogenesis: an organizing principle for drug discovery?
/ Nat Rev Drug Discov
6
: 273~286
[journal]
Faivre S.
/ 2007
/ Molecular basis for sunitinib efficacy and future clinical development
/ Nat Rev Drug Discov
6
: 734~745
[journal]
Wilhelm S.
/ 2006
/ Discovery and development of sorafenib : a multikinase inhibitor for treating cancer
/ Nat Rev Drug Discov
5
: 835~844
[journal]
Motzer RJ.
/ 2006
/ Targeted therapy for metastatic renal cell carcinoma
/ J Clin Oncol
24
: 5601~5608
[journal]
Bergers G.
/ 2008
/ Modes of resistance to anti-angiogenic therapy
/ Nat Rev Cancer
8
: 592~603
[journal]
Verheul HM.
/ 2007
/ Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
/ Nat Rev Cancer
7
: 475~485
[journal]
Urbich C.
/ 2008
/ Role of microRNAs in vascular diseases, inflammation, and angiogenesis
/ Cardiovasc Res
79
: 581~588
[journal]
Wang S.
/ 2008
/ The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
/ Dev Cell
15
: 261~271
[journal]
Wang S.
/ 2009
/ AngiomiRs-key regulators of angiogenesis
/ Curr Opin Genet Dev
19
: 205~211
[journal]
Albelda SM
/ 1993
/ Role of integrins and other cell adhesion molecules in tumor progression and metastasis
/ Lab Invest
68
: 4~17
[journal]
Roberts DD
/ 1996
/ Regulaton of tumor growth and metastasis by thrombospondin-1
/ FASEB J
10
: 1183~1191
[journal]
Morandi V.
/ 1993
/ Role of thrombospondin in the adhesion of human endothelial cells in primary culture
/ In Vitro Cell Dev Biol Anim
29
: 585~591
[journal]
Dreyfus M.
/ 1988
/ An apparent dependence on synthesis and on preformed fibrillar matrix
/ Eur J Cell Biol
47
: 275~282
[journal]
Lawler J
/ 2000
/ The functions of thrombospondin-1 and -2
/ Curr Opin Cell Biol
2
: 634~640
[journal]
Wang TN.
/ 1995
/ The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen
/ Am J Surg
170
: 502~505
[journal]
Lawler J.
/ 1986
/ Thrombin and chymotrypsin interactions with thrombospondin
/ Ann NY Acd Sci
485
: 273~287
[journal]
Bein K.
/ 2000
/ Regulation of metalloproteinase activity
/ J Biol Chem
275
: 32167~32173
[journal]
Iruela-Arispe ML.
/ 1999
/ Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1repeats
/ Circulation
100
: 1423~1431
[journal]
Chen H.
/ 1996
/ Metabolism of thrombospondin 2. Binding and degradation by 3t3 cells and glycosaminoglycan-variant Chinese hamster ovary cells
/ J Biol Chem
271
: 15993~15999
[journal]
Murphy-Ullrich JE.
/ 1992
/ Transforming growth factor-beta complexes with thrombospondin
/ Mol Biol Cell
3
: 181~188
[journal]
Ribeiro SM.
/ 1999
/ The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factorbeta
/ J Biol Chem
274
: 13586~13593
[journal]
Good DJ.
/ 1990
/ A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
/ Proc Natl Acad Sci USA
87
: 6624~6628
[journal]
Tolsma SS.
/ 1993
/ Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
/ J Cell Biol
122
: 497~511
[book]
Dawson DW.
/ 1999
/ Thrombospondin as an inhibitor of angiogenesis. In Antiangiogenic agents in cancer therapy
/ Human Press Inc
: 185~203
[journal]
Kyriakides TR.
/ 1999
/ Mice that lack the angiogenesis inhibitor, thrombospondin-2, mount an altered foreign body reaction characterized by increased vascularity
/ Proc Natl Acd Sci USA
96
: 4449~4454
[journal]
Weinstat-Saslow DL.
/ 1994
/ Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis
/ Cancer Res
54
: 6504~6511
[journal]
Bleuel K.
/ 1999
/ Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization
/ Proc Natl Acad Sci USA
96
: 2065~2070
[journal]
Streit M.
/ 1999
/ Thrombospondin-2 : a potent endogenous inhibitor of tumor growth and angiogenesis
/ Proc Natl Acad Sci USA
96
: 14888~14893
[journal]
Greenwalt DE.
/ 1992
/ Membrane glycoprotein CD36 : A review of its roles in adherence, signal transduction, and transfusion medicine
/ Blood
80
: 1105~1115
[journal]
Jimenez B.
/ 2000
/ Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
/ Nat Med
6
: 41~48
[journal]
Vogel T.
/ 1993
/ Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type 1 repeats of thrombospondin
/ J Cell Biochem
53
: 74~84
[journal]
Kanda S.
/ 1999
/ Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis
/ Exp Cell Res
252
: 262~272
[journal]
Roberts.
/ 2012
/ The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47
/ Matrix Biol
31
: 162~169
[journal]
Isenberg JS.
/ 2009
/ Regulation of nitric oxide signalling by thrombospondin 1 : implications for anti-angiogenic therapies
/ Nat Rev Cancer
9
: 182~194
[journal]
Kaur S.
/ 2010
/ Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47
/ J Biol Chem
285
: 38923~38932
[journal]
Gardai SJ.
/ 2005
/ Cell-surface calreticulin initiates clearance of viable or apoptotic cells through transactivation of LRP on the phagocyte
/ Cell
123
: 321~334
[journal]
Chao MP.
/ 2010
/ Calreticulin is the dominant pro-phagocytic signal on multiple human cancers andis counterbalanced by CD47
/ Sci Transl Med
2
: 63ra94~
[journal]
Chao MP.
/ 2011
/ Programmed cell removal : a new obstacle in the road to developing cancer
/ Nat Rev Cancer
12
: 58~67
[journal]
Oldenborg PA.
/ 2000
/ Role of CD47 as a marker of self on red blood cells
/ Science
288
: 2051~2054
[journal]
Blazar BR.
/ 2001
/ CD47(integrin-associated protein)engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells
/ J Exp Med
194
: 541~549
[journal]
Barclay AN.
/ 2014
/ The interaction between signal regulatory protein alpha(SIRPα)and CD47 : structure, function, and therapeutic target
/ Annu Rev Immunol
32
: 25~50
[journal]
Yamao T.
/ 2002
/ Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1
/ J Biol Chem
277
: 39833~39839
[journal]
Olsson M.
/ 2005
/ Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia
/ Blood
105
: 3577~3582
[journal]
Jaiswal S.
/ 2009
/ CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis
/ Cell
138
: 271~285
[journal]
Majeti R.
/ 2009
/ CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
/ Cell
138
: 286~299
[journal]
Rendtlew Danielsen JM.
/ 2007
/ Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma
/ Br J Haematol
138
: 756~760
[journal]
Chan KS.
/ 2009
/ Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumorinitiating cells
/ Proc Natl Acad Sci USA
106
: 14016~14021
[journal]
Chan KS.
/ 2010
/ Cancer stem cells in bladder cancer : a revisited and evolving concept
/ Curr Opin Urol
20
: 393~397
[journal]
Liu X.
/ 2015
/ CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
/ Nat Med
21
: 1209~1215
[journal]
Kaur S
/ 2013
/ Thrombospondin-1 signaling through CD47 inhibits self renewal by regulating c-myc and other stem cell transcription factors
/ Sci Rep
3
: 1673~
[journal]
Wang W.
/ 2015
/ MicroRNAs in tumor angiogenesis
/ Life Sci
136
: 28~35